FSD Pharma Inc. Rings the Opening Bell

fsd
Written By Padilla Development

FSD Pharma Inc. (Nasdaq: HUGE), a specialty, biotech pharmaceutical R&D company, visited the Nasdaq MarketSite in Times Square.

In honor of the occasion, Dr. Raza Bokhari, Chairman & CEO, rang the Opening Bell.

Click here to watch the full video

Padilla Development
Previous

SkinJect, an innovator in skin cancer treatment, is backed by US healthcare private equity and institutional investors, including RBx Capital, LP and Velocity Fund Partners
Next

FSD Pharma aims to initiate a Phase 2 coronavirus treatment trial by end 2020 as it files IND